Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children
-
Published:2023-07-13
Issue:1
Volume:8
Page:
-
ISSN:2059-0105
-
Container-title:npj Vaccines
-
language:en
-
Short-container-title:npj Vaccines
Author:
Kazmin Dmitri, Clutterbuck Elizabeth A., Napolitani Giorgio, Wilkins Amanda L., Tarlton Andrea, Thompson Amber J., Montomoli Emmanuele, Lapini Guilia, Bihari Smiti, White Rachel, Jones Claire, Snape Matthew D., Galal Ushma, Yu Ly-Mee, Rappuoli Rino, Del Giudice Giuseppe, Pollard Andrew J.ORCID, Pulendran BaliORCID
Abstract
AbstractThe pediatric population receives the majority of vaccines globally, yet there is a paucity of studies on the transcriptional response induced by immunization in this special population. In this study, we performed a systems-level analysis of immune responses to the trivalent inactivated influenza vaccine adjuvanted with MF-59 in children (15–24 months old) and in young, healthy adults. We analyzed transcriptional responses elicited by vaccination in peripheral blood, as well as cellular and antibody responses following primary and booster vaccinations. Our analysis revealed that primary vaccination induced a persistent transcriptional signature of innate immunity; booster vaccination induced a transcriptional signature of an enhanced memory-like innate response, which was consistent with enhanced activation of myeloid cells assessed by flow cytometry. Furthermore, we identified a transcriptional signature of type 1 interferon response post-booster vaccination and at baseline that was correlated with the local reactogenicity to vaccination and defined an early signature that correlated with the hemagglutinin antibody titers. These results highlight an adaptive behavior of the innate immune system in evoking a memory-like response to secondary vaccination and define molecular correlates of reactogenicity and immunogenicity in infants.
Funder
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference53 articles.
1. Shang, M., Blanton, L., Brammer, L., Olsen, S. J. & Fry, A. M. Influenza-associated pediatric deaths in the United States, 2010-2016. Pediatrics https://doi.org/10.1542/peds.2017-2918 (2018) 2. Wong, K. K. et al. Influenza-associated pediatric deaths in the United States, 2004-2012. Pediatrics 132, 796–804 (2013). 3. Jefferson, T., Rivetti, A., Di Pietrantonj, C. & Demicheli, V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst. Rev. 2, CD004879 (2018). 4. Block, S. L. et al. Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. Pediatr. Infect. Dis. J. 31, e92–e98 (2012). 5. Della Cioppa, G., Vesikari, T., Sokal, E., Lindert, K. & Nicolay, U. Trivalent and quadrivalent MF59((R))-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. Vaccine 29, 8696–8704 (2011).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|